loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X

Technical details about Hydronidone, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: Hydronidone, 851518-71-3, F 351, F-351, N-(4-hydroxyphenyl)-5-methyl-2-1h-pyridone, N-(4-hydroxyphenyl)-5-methyl-2-pyridone
Molecular Formula
C12H11NO2
Molecular Weight
201.22  g/mol
InChI Key
NETTXQJYJRFTFS-UHFFFAOYSA-N
FDA UNII
RXQ128313W

Hydronidone has antifibrotic activity.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-(4-hydroxyphenyl)-5-methylpyridin-2-one
2.1.2 InChI
InChI=1S/C12H11NO2/c1-9-2-7-12(15)13(8-9)10-3-5-11(14)6-4-10/h2-8,14H,1H3
2.1.3 InChI Key
NETTXQJYJRFTFS-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=CN(C(=O)C=C1)C2=CC=C(C=C2)O
2.2 Other Identifiers
2.2.1 UNII
RXQ128313W
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Hydronidone

2. N-(4-hydroxyphenyl)-5-methyl-2-pyridone

2.3.2 Depositor-Supplied Synonyms

1. Hydronidone

2. 851518-71-3

3. F 351

4. F-351

5. N-(4-hydroxyphenyl)-5-methyl-2-1h-pyridone

6. N-(4-hydroxyphenyl)-5-methyl-2-pyridone

7. Rxq128313w

8. F-351;f351

9. 1-(4-hydroxyphenyl)-5-methyl-1h-pyridine-2-one

10. Schembl143564

11. Unii-rxq128313w

12. 1-(4-hydroxyphenyl)-5-methylpyridin-2-one

13. Chembl4297288

14. Dtxsid40459058

15. Zinc21981322

16. Akos016006473

17. Db06299

18. Sb18945

19. F351

20. Db-115847

21. Hy-100438

22. Cs-0019024

23. Ft-0669968

24. Ft-0669969

25. Q27288328

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 201.22 g/mol
Molecular Formula C12H11NO2
XLogP31.5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count1
Exact Mass201.078978594 g/mol
Monoisotopic Mass201.078978594 g/mol
Topological Polar Surface Area40.5 Ų
Heavy Atom Count15
Formal Charge0
Complexity312
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in liver disease.


Post Enquiry
POST ENQUIRY